Titration of serum p53 antibodies in patients with gastric cancer: A single-institute study of 40 patients

Gastric Cancer

Volumn 8, Issue 4, 2005, Pages 214-219

  Shimizu, Keiji ^a   Ueda, Yuji ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Gastric cancer; p53 Antibody; Tumor marker

Indexed keywords

CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; EARLY CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 28244472036     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-005-0337-4     Document Type: Article

References (32)

1. EP Diamandis 1992 Oncogenes and tumor suppressor genes: new biochemical tests Crit Rev Clin Lab Sci 29 269 305
2. A Levine J Momand C Finlay 1991 The p53 tumor suppressor gene Nature 351 453 5
3. T Soussi Y Legros R Lubin K Ory B Schlichtholz 1994 Multifactorial analysis of p53 alteration in human cancer: a review Int J Cancer 57 1 9
4. F Chang S Syrjanen K Syrjanen 1995 Implications of the p53 tumor suppressor gene in clinical oncology J Clin Oncol 13 1009 22
5. D Lane S Benchimol 1990 p53: oncogene or anti-oncogene? Genes Dev 4 1 8
6. A Davidoff P Humphrey J Iglehart J Marks 1991 Genetic basis for p53 overexpression in human breast cancer Proc Natl Acad Sci USA 88 5006 10
7. LV Crawford DC Pim RD Bulbrook 1982 Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer Int J Cancer 30 403 8
8. FC Caron LF May H Mouriesse J Lemerle K Chandrasekaran P May 1987 Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma Int J Cancer 39 185 9
9. K Angelopoulou EP Diamandis DJA Sutherland JA Kellen PS Bunting 1994 Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers Int J Cancer 58 480 7
10. R Lubin B Schlichtholz JL Teillaud E Garay A Bussel C Wild 1995 p53 antibodies in patients with various types of cancer: assay, identification and characterization Clin Cancer Res 1 1463 9
11. JP Peyrat J Bonneterre R Lubin L Vanlemmens J Fournier T Soussi 1995 Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer Lancet 345 621 2
12. T Lethinen T Luostarinen J Dillner 1996 Serum p53 accumulation and altered antibody response to Epstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin Br J Haematol 93 104 10
13. MC Breveren von MC Hollstein HM Cawley VGM De Benedetti WP Bennett L Liang 1996 Circulating anti-p53 antibodies in oesophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors Cancer Res 56 4917 21
14. J Marxsen W Schmiegel C Roder R Harder H Juhl D Henne-Bruns 1994 Detection of the anti-p53 antibody response in malignant and benign pancreatic disease Br J Cancer 70 1031 4
15. K Nakajima T Suzuki H Shimada H Hayashi A Takeda T Ochiai 1999 Detection of preoperative serum anti-p53 antibodies in gastric cancer Tumor Biol 20 147 52
16. GE Trivers HL Cawley VM DeBenedetti M Hollstein MJ Marion WP Bennett 1995 Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride J Natl Cancer Inst 87 1400 7
17. P Hammel B Boissier MT Chaumette P Piedbois N Rotman JC Kouyoumdjian 1997 Detection and monitoring of serum p53 antibodies in patients with colorectal cancer Gut 40 356 61
18. JG Houbiers SH van der Burg LM van de Watering RA Tollenaar A Brand CJ van de Velde 1995 Antibodies against p53 are associated with poor prognosis of colorectal cancer Br J Cancer 72 637 41
19. Y Maehara Y Kakeji A Watanabe H Baba H Kusumoto S Kohnoe 1999 Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma Cancer 85 302 8
20. P Würl F Weigmann A Meye M Fittkau U Rose D Berger 1997 Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance Scand J Gastroenterol 32 1147 51
21. CW Wu YY Lin GD Chen CW Chi DP Carbone JY Chen 1999 Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade Br J Cancer 80 483 8
22. G Shiota M Ishida N Noguchi Y Takano K Oyama M Okubo 1998 Clinical significance of serum p53 antibody in patients with gastric cancer Res Commun Mol Pathol Pharmacol 99 41 51
23. H Shimada T Ochiai F Nomura 2003 Titration of serum p53 antibodies in 1085 patients with various types of malignant tumors Cancer 97 682 9
24. AO Chan KM Chu SK Lam BC Wong KF Kwok S Law 2003 Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer J Clin Oncol 21 2288 93
25. M Juhasz MP Ebert HU Schulz C Rocken B Molnar Z Tulassay 2003 Dual role of serum soluble E-cadherin as a biological marker of metastatic development in gastric cancer Scand J Gastroenterol 38 850 5
26. K Tanaka C Miki R Wakuda M Kobayashi H Tonouchi M Kusunoki 2004 Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma Scand J Gastroenterol 39 754 60
27. Y Kodera Y Yamamura A Torii K Uesaka T Hirai K Yasui 1996 The prognosis value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer Am J Gastroenterol 91 49 53
28. S Ishigami S Natsugoe S Hokita X Che K Tokuda A Nakajo 2001 Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer J Clin Gastroenterol 32 41 4
29. R Lubin G Zalcman L Bouchet J Tredaniel Y Legros D Cazals 1995 Serum p53 antibodies as early markers of lung cancer Nature Med 1 701 2
30. G Zalcman B Schlichtholz J Tredaniel T Urban R Lubin I Dubois 1998 Monitoring of p53 auto antibodies in lung cancer during therapy: relationship to response to treatment Clin Cancer Res 4 1359 66
31. P Berloco F Russo F Cariola M Gentile P Giorgio ML Caruso 2003 Low presence of p53 abnormalities in H. pylori-infected gastric mucosa and in gastric adenocarcinoma J Gastroenterol 38 28 36
32. G Tan D Xing S Tan Q Chen 2004 Rapid and sensitive immunomagnetic- electrochemiluminescent detection of p53 antibodies in human serum J Immunol Methods 288 47 54